Medical Marijuana Market to Experience Blatant Growth at 35.4% of CAGR during the Forecast Period 2019-2023

According to Market Research Future, the Global Medical Marijuana Market to provide readers with a clear view of the market’s likely growth trajectory over the coming years. The report utilizes historical trends of the Global Medical Marijuana Market and present statistics to derive.

Pune, India - February 12, 2019 /MarketersMedia/ —

Medical Marijuana Market - Synopsis

Global Medical Marijuana Market is forecasted to expand remarkably at a CAGR of over 35.4% during the forecast period of 2018-2023. Medical marijuana or medical cannabis is the unprocessed marijuana plant or its extracts that are used to treat the symptoms of various diseases and other medical conditions.

Marijuana consists of chemical components cannabinoids,  which can be used as medicine to treat the symptoms caused by illness. Medical marijuana plant or extract of the plant is used for the treatment. The increasing number of chronic diseases, rising acceptance of medical marijuana in healthcare and increasing research and development activities are the major factors driving the growth of the global medical marijuana market. Additionally, increasing U.S. Food and Drug Administration (FDA) approvals for drugs containing cannabinoids are contributing to the growth of the market. For instance, in June 2018, U.S. Food and Drug Administration (FDA) has approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of epilepsy.

Request Sample Copy at https://www.marketresearchfuture.com/sample_request/6470

The stringent regulatory environment for product approval, increasing use of marijuana for recreational use and side effects caused by long-term use of marijuana are likely to hinder market growth during the forecast period.

Top Players:

The key players profiled by MRFR that are operating in the global medical marijuana market are Canopy Growth, Aurora Cannabis, Inc., Cannabis Sativa, Inc, GW Pharmaceuticals plc, United Cannabis, MGC Pharma, Aphria, Inc., Tilray, Emerald Health Therapeutics [Canada] Inc., GBSciences, Inc., CanniMed Ltd., Medical Marijuana, Inc, Cara Therapeutics, and Greengro Technologies.

Segmentation:

The global medical marijuana market has been segmented on the basis of application, route of administration and distribution channel.

On the basis of application, the market has been classified as Alzheimer’s disease, cancer, mental health conditions, multiple sclerosis, muscle spasms, glaucoma, and human immunodeficiency virus, acquired immunodeficiency syndrome (HIV/AIDS). Mental health conditions are differentiated into schizophrenia and posttraumatic stress disorder (PTSD).

The route of administration segment has been further divided into oral, topical, inhalation and sublingual. The topical segment has been classified into ointments, lotions, creams, gels, and poultice.

The market, by distribution channel, has been segmented into dispensaries and online platforms.

Industry Updates:

In January 2019, it has been announced by the Arkansans Department of Health that the patients who are approved for purchasing medical; marijuana will receive patient cards by February 2019.

In January 2019, it has been announced that within next few days residents in Ohio will be able to purchase marijuana for medical purposes.

In January 2019, Trulieve, Florida's largest and first medical marijuana provider, has signed a deal to bring high-end edible marijuana products to Florida and will soon be made available for the registered medical marijuana patients in the form of cannabis chocolates, granola bars, honey, fruit leather, olive oil and more.

Medical Marijuana Market - Regional Analysis:

The market in the Americas is expected to dominate the global medical marijuana market during the forecast period owing to the increasing prevalence of chronic diseases, increasing number of cannabinoid drug approvals by regulatory authorities, and increasing expenditure on research and development of medical marijuana. The European market is expected to be the second-largest due to the favorable policies implemented by government and regulatory authorities and increasing applications of marijuana in healthcare. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to the increasing number of mental disorders and increasing expenditure on healthcare research and development. The market in the Middle East & Africa is likely to account for the smallest share of the global medical marijuana market. The market growth in this region can be attributed to the rising acceptance of medical marijuana in the treatment of illness and favorable government policies.

Browse Complete 85 Pages Premium Research Report Enabled with Respective 30+ Tables and Figures at https://www.marketresearchfuture.com/reports/medical-marijuana-market-6470

Some Points From TOC of Medical Marijuana Market Research Report – Forecast to 2023:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

TOC CONTINUED…!

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: Market Research Future
Email: Send Email
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India
Phone: 6468459312
Website: https://www.marketresearchfuture.com/reports/medical-marijuana-market-6470

Source URL: https://marketersmedia.com/medical-marijuana-market-to-experience-blatant-growth-at-354-of-cagr-during-the-forecast-period-2019-2023/481621

Source: MarketersMedia

Release ID: 481621

Latest News

Nissan ex-boss Ghosn's new lawyer questions handling of case

Feb 20, 2019

TOKYO — The newly appointed star defender for former Nissan chairman Carlos Ghosn said Wednesday that he believes the case against his client does "not meet international standards" and could scare international businesses away from Japan. Junichiro Hironaka, who was appointed part of Ghosn's defense team last week, also said he believes his trial might not get underway until after the summer. That could mean months more of detention for the Brazilian-born French auto-industry veteran, who has twice sought and failed to gain release on bail after his Nov. 19 arrest. Hironaka said his gut feeling is that Ghosn, the...

Unlike men's World Cup, no open vote on women's event host

Feb 20, 2019

LONDON — FIFA will still decide the host of the Women's World Cup in secret, unlike the new open vote held last year for host of the 2026 men's tournament. The 2023 Women's World Cup bidding process was launched Tuesday, and FIFA adopted many of the rigorous checks and scrutiny that prospective men's hosts now have to go through. But the final decision is a very different process. Following corruption investigations into the vote for men's hosts in 2018 and 2022, FIFA removed the decision from its ruling committee and gave it to all member associations. When it came to...

Japan trade deficit highest in 5 yrs, hit by China doldrums

Feb 20, 2019

TOKYO — Japan reports its exports tumbled 8.4 percent in January from a year earlier, as slowing Chinese growth pushed its monthly trade deficit to the highest level in nearly five years. Exports to all of Asia dropped 13 percent year-on-year, largely due to the 17 percent plunge in shipments to China, where growth recently has fallen to its slowest pace in three decades. The politically delicate trade surplus with the United States rose 5 percent to $3.3 billion, as exports climbed nearly 7 percent helped by rising shipments of cars and power generating machinery. But imports of American goods...

UK expands no-fly zone for drones around airports

Feb 20, 2019

LONDON — The no-fly zone for drones around British airports is being extended to 5 kilometers (3.1 miles) in an attempt to avert disruptions like the December groundings of flights at Gatwick Airport, officials said Wednesday. The Department for Transport said the zone will widen on March 13 from the current 1 kilometer (0.6 miles). Officials are also working on new legislation to give police more powers to stop and search people suspected of using drones maliciously. Transport Secretary Chris Grayling said people who fly drones near airports "are not only acting irresponsibly, but criminally, and could face imprisonment." More...

Twitter tightens up EU political ad rules ahead of election

Feb 20, 2019

LONDON — Twitter said Tuesday it is tightening up rules for European Union political ads ahead of bloc-wide elections this spring, following similar moves by fellow tech giants Facebook and Google. The social media company said it is extending restrictions already in place for federal elections in the United States. Under the new rules, which will also apply in Australia and India, political advertisers will need to be certified. It's also taking steps to increase transparency. Ads, in the form of "promoted tweets," from the past seven days will be stored in a publicly accessible database showing how much was...

About Us

Frontal Report is an emerging leader in all forms of media. We aim to be the leading news brand for readers around the world.

Contact us: sales[at]frontalreport.com

Subscribe Now!